X4 Pharmaceuticals Beats Loss Expectations, Misses Revenue Mark
Update: 2025-11-05
Description
X4 Pharmaceuticals Beats Loss Expectations but Falls Short on Revenue: Despite reporting a smaller loss than anticipated, the Boston-based company missed revenue targets, posting $1.8 million against the projected $1.9 million. A mixed bag of results leaves investors with a cautious outlook.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
